Home › Focal Segmental Glomerulosclerosis › Missouri › Kansas City
Focal Segmental Glomerulosclerosis clinical trials in Kansas City, MO
4 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Nephrotic Syndrome Study Network
RecruitingObservational study
- Children's Mercy Hospital, Kansas City
NEPTUNE Match Study
Recruiting
- Children's Mercy Hospital, Kansas City
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
RecruitingPhase 2
- Children's Mercy Hospitals and Clinics, Kansas City
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
RecruitingPhase 3
- Children's Mercy Research Institute, Kansas City
Focal Segmental Glomerulosclerosis trials in other cities
- Philadelphia, PA9 studies
- Durham, NC8 studies
- New York City, NY7 studies
- Ann Arbor, MI6 studies
- Los Angeles, CA6 studies
- Queens, NY6 studies
- Miami, FL6 studies
- Atlanta, GA5 studies
- Houston, TX5 studies
- Chicago, IL4 studies
- Dallas, TX4 studies
- Cleveland, OH4 studies
Other studies in Kansas City
- Breast Cancer34 studies
- Non-Small Cell Lung Cancer31 studies
- Heart Failure25 studies
- Cancer (all types)21 studies
- Lung Cancer19 studies
- Colorectal Cancer16 studies
- Metastatic Cancer15 studies
- Acute Myeloid Leukemia15 studies
- Prostate Cancer14 studies
- Obesity11 studies
- Ovarian Cancer11 studies
- Type 2 Diabetes11 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.